Zimmer Biomet Holdings, Inc.

NYSE:ZBH

Medical - Devices

Healthcare
$103.32 +1.00%

+$0.87 today

Market cap
$19.55B
Beta
0.47
P/E (TTM)
22.5
EPS (TTM)
$3.90
Dividend yield
1.09%
52W Low $79.12High $108.29

Volume 2.34M

Average 2.28M

ZBH Common Stock

The par or stated value of issued common shares, plus paid-in capital where reported together.

Zimmer Biomet Holdings, Inc.NYSE: ZBH

Common Stock · Q2 FY2026 · quarter ended Jun 2026

Common stock broadly unchanged from a year ago

Common stock stood at $3.2M at the end of Q2 FY2026, up 0.0% from a year earlier and up 0.0% from the prior quarter. Over 3 fiscal years it compounded at +1.1% a year.

Context

  • Common stock amounted to 0.0% of total assets at the end of Q2 FY2026, unchanged from a year earlier.
  • Common stock increased in 1 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether common stock keeps rising in the next quarterly balance sheet after a +0.0% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterJun 2026
$3.2M+0.0% QoQ
Last fiscal yearDec 2025
$3.2M+0.0% YoY
Year agoJun 2025
$3.2M+0.0% since
Common Stock past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+0.0%——
1 year+0.0%——
3-year CAGR+1.1%——
5-year CAGR——
10-year CAGR——

Common Stock history

USD · from the balance sheet

Latest · FY2025
3.2M USD
Year-over-year change
+0.0%
4-year CAGR
+0.8%

Common Stock vs competitors

How ZBH compares with its peers on the latest reported figures

  • Peers report in different currencies, so common stock is compared through growth and share of total assets rather than absolute size.
  • Its year-over-year change of +0.0% is the 4th highest of 10, against a peer median of +0.0%.
  • Common stock amounts to 0.0% of total assets for ZBH, versus a peer median of 0.3%.
ZBH Competitors
Common Stock for ZBH and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
EWEdwards Lifesciences CorporationJun 2026$661.7M USD+0.6%+0.6%4.8%
PHGKoninklijke Philips N.V.Jun 2026€197M EUR+2.1%+2.7%0.7%
SNNSmith & Nephew plcDec 2025$175M USD+0.0%+0.0%1.7%
SYKStryker CorporationJun 2026$38M USD+0.0%+0.0%0.1%
BSXBoston Scientific CorporationJun 2026$17M USD+0.0%+0.0%0.0%
GEHCGE HealthCare Technologies Inc.Jun 2026$5M USD+0.0%-92.4%0.0%
OFIXOrthofix Medical Inc.Mar 2026$4.04M USD+3.3%+25.5%0.5%
ZBHZimmer Biomet Holdings, Inc.Jun 2026$3.2M USD+0.0%+1.1%0.0%
ALGNAlign Technology, Inc.Jun 2026$7K USD+0.0%-4.4%0.0%
MDTMedtronic plcJul 2026-$247M USD-782.1%—0.3%
Peer median (excluding ZBH) —+0.0%+0.0%0.3%

Competitors are the stored peer set for ZBH. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents378.1M375.7M415.8M525.5M591.9M
Short-term Investments00000
Net Receivables1.26B1.38B1.44B1.48B1.7B
Inventory2.15B2.15B2.39B2.24B2.29B
Other Current Assets772.6M324.5M366.1M430M537.2M
Total Current Assets4.89B4.43B4.61B4.67B5.12B
Property, Plant & Equipment (Net)1.84B1.87B2.06B2.05B2.21B
Goodwill8.92B8.58B8.82B8.95B9.95B
Intangible Assets5.53B5.06B4.86B4.6B4.72B
Long-term Investments27.6M16.6M31.6M73.2M39.4M
Tax Assets00000
Other Non-current Assets2.25B1.11B1.12B1.02B1.1B
Total Non-current Assets18.57B16.64B16.89B16.69B17.97B
Total Assets23.46B21.07B21.5B21.37B23.09B
Account Payables306.5M354.1M410.6M194.6M303M
Short-term Debt1.61B544.3M900M863M587.1M
Tax Payables62M38.5M61.2M00
Deferred Revenue00000
Other Current Liabilities640.5M502.8M326.1M286M382M
Total Current Liabilities3.47B2.36B2.86B2.45B2.58B
Long-term Debt5.46B5.15B4.87B5.34B6.93B
Deferred Tax Liabilities558.5M474.8M357.6M352.5M244.1M
Deferred Revenue (Non-current)00000
Other Non-current Liabilities1.3B1.05B925.9M744.1M626.1M
Total Non-current Liabilities7.32B6.68B6.15B6.44B7.8B
Total Liabilities10.79B9.04B9.01B8.89B10.39B
Common Stock3.1M3.1M3.2M3.2M3.2M
Retained Earnings10.29B9.56B10.38B11.1B11.61B
Accumulated OCI(231.6M)(179.3M)(191M)(262.8M)(205.7M)
Other Stockholders Equity00000
Minority Interest5.7M6.7M7.7M8.1M8.1M
Total Equity12.67B12.03B12.48B12.48B12.71B
Total Debt7.07B5.7B5.77B6.2B7.52B
Net Debt6.69B5.32B5.35B5.68B6.93B

Zimmer Biomet Holdings, Inc.

NYSE:ZBH

Intrinsic Alpha fair value

Locked

Current Price

$103.32

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.